Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Andrei Shanko"'
Autor:
Andrei Shanko, Marina Shuklina, Anna Kovaleva, Yana Zabrodskaya, Inna Vidyaeva, Aram Shaldzhyan, Artem Fadeev, Alexander Korotkov, Marina Zaitceva, Liudmila Stepanova, Liudmila Tsybalova, Larisa Kordyukova, Anton Katlinski
Publikováno v:
Vaccines, Vol 8, Iss 4, p 756 (2020)
A series of commercial inactivated influenza vaccines (IIVs) used in the Russian National Immunization Program were characterized to evaluate their protective properties on an animal model. Standard methods for quantifying immune response, such as he
Externí odkaz:
https://doaj.org/article/0230167dff754fa4bf027d3e3e6bc5ee
Characterization of Inactivated Influenza Vaccines Used in the Russian National Immunization Program
Publikováno v:
Vaccines, Vol 8, Iss 3, p 488 (2020)
Background: today’s standard quality control methods used to control the protein composition of inactivated influenza vaccines only take into account a few key reference components. They do not allow for thorough characterization of protein composi
Externí odkaz:
https://doaj.org/article/c9c8b6e0d36f49b58b0bb050bc1ee635
Autor:
Inna G. Vidyaeva, Artem Fadeev, Andrei Shanko, Larisa V. Kordyukova, Aram A. Shaldzhyan, Liudmila A. Stepanova, Yana A. Zabrodskaya, Marina A. Shuklina, Alexander V. Korotkov, Anton Katlinski, Anna A. Kovaleva, Liudmila M. Tsybalova, Marina Zaitceva
Publikováno v:
Vaccines, Vol 8, Iss 756, p 756 (2020)
Vaccines
Volume 8
Issue 4
Vaccines
Volume 8
Issue 4
A series of commercial inactivated influenza vaccines (IIVs) used in the Russian National Immunization Program were characterized to evaluate their protective properties on an animal model. Standard methods for quantifying immune response, such as he
Characterization of Inactivated Influenza Vaccines Used in the Russian National Immunization Program
Publikováno v:
Vaccines
Volume 8
Issue 3
Vaccines, Vol 8, Iss 488, p 488 (2020)
Volume 8
Issue 3
Vaccines, Vol 8, Iss 488, p 488 (2020)
Background: today&rsquo
s standard quality control methods used to control the protein composition of inactivated influenza vaccines only take into account a few key reference components. They do not allow for thorough characterization of protei
s standard quality control methods used to control the protein composition of inactivated influenza vaccines only take into account a few key reference components. They do not allow for thorough characterization of protei